The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature
Abstract
Imaging that can detect pathophysiologic change in the brain holds great promise for diagnostic assessment of patients with Alzheimer disease (AD) and dementia. Although a previous metaanalysis centering on literature from 1990 to 2000 showed a summary accuracy of 86% for (18)F-FDG PET for AD diagnosis, the clinical value was considered uncertain because of methodologic shortcomings. Review of the recent literature since 2000 demonstrates that the evidence for (18)F-FDG PET in assessment of dementia has increased with new studies that include autopsy confirmation, wide-diagnostic-spectrum recruitment in primary care settings, historical and prospective cohort studies, and multicenter data analyses. These data support the role of (18)F-FDG PET as an effective and useful adjunct to other diagnostic information in the assessment of patients with symptoms of dementia. Findings are in line with recently revised diagnostic criteria of AD that for the first time recognize the unique role of biomarker evidence in disease definition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 2×
“These in vivo imaging findings are consistent with the idea of progressive pathologic spreading in AD from the hippocampal formation to the association cortex (61) and with the Braak and Braak staging model of neurofibrillary tangle pathology in AD (62).”
Statistical parametric maps in functional imaging: A general linear approach
Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J. ‐., Frith, C. D., & Frackowiak, R. S. J. (1994) · Human Brain Mapping · doi:10.1002/hbm.460020402 · Cited by 9,688
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationFrontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,850
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G. G., & Heyman, A. (2002) · Principles and Practice of Geriatric Psychiatry · doi:10.1002/0470846410.ch42(iii · Cited by 2,410
Revising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869 · cited 1×
“18F-FDG PET is therefore also being considered as an imaging biomarker for AD before onset of dementia (66) and in clinical trials (67).”
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802
Self-citationDoody, R. S., Stevens, J. C., Beck, C., Dubinsky, R. M., Kaye, J. A., Gwyther, L., Mohs, R. C., Thal, L. J., Whitehouse, P. J., DeKosky, S. T., et al. (2001) · Neurology · doi:10.1212/wnl.56.9.1154 · Cited by 1,720
SEMANTIC DEMENTIA: PROGRESSIVE FLUENT APHASIA WITH TEMPORAL LOBE ATROPHY
HODGES, J. R., PATTERSON, K., OXBURY, S., & FUNNELL, E. (1992) · Brain · doi:10.1093/brain/115.6.1783 · Cited by 1,710
Knopman, D. S., DeKosky, S. T., Cummings, J. L., Chui, H., Corey–Bloom, J., Relkin, N., Small, G. W., Miller, B., & Stevens, J. C. (2001) · Neurology · doi:10.1212/wnl.56.9.1143 · Cited by 1,410
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Self-citationFrequent amyloid deposition without significant cognitive impairment among the elderly
Aizenstein, H. J., Nebes, R. D., Saxton, J. A., Price, J. C., Mathis, C. A., Tsopelas, N. D., Ziolko, S. K., James, J. A., Snitz, B. E., Houck, P. R., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1509 · Cited by 1,059
(1995) · PubMed Central · doi:10.2967/jnumed.120.252510a · Cited by 996
Self-citationSilverman, D. H. S., Small, G. W., Chang, C. Y., Lu, C. S., de Aburto, M. A. K., Chen, W., Czernin, J., Rapoport, S. I., Pietrini, P., Alexander, G. E., et al. (2001) · JAMA · doi:10.1001/jama.286.17.2120 · Cited by 951
The neuropathology of probable Alzheimer disease and mild cognitive impairment
Schneider, J. A., Arvanitakis, Z., Leurgans, S. E., & Bennett, D. A. (2009) · Annals of Neurology · doi:10.1002/ana.21706 · Cited by 935
MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease
Jack, C. R., Petersen, R. C., O'Brien, P. C., & Tangalos, E. G. (1992) · Neurology · doi:10.1212/wnl.42.1.183 · Cited by 878
Alzheimer's Disease--Genotypes, Phenotype, and Treatments
Selkoe, D. J. (1997) · Science · doi:10.1126/science.275.5300.630 · Cited by 875
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
Herholz, K., Salmon, E., Perani, D., Baron, J.-C., Holthoff, V., Frölich, L., Schönknecht, P., Ito, K., Mielke, R., & Kalbe, E. (2002) · NeuroImage · doi:10.1006/nimg.2002.1208 · Cited by 832 · cited 1×
“These procedures result in an observer-independent, quantitative mapping of regional glucose metabolic abnormalities (58,60).”
Self-citationRELATION BETWEEN PHYSIOLOGICAL FUNCTION AND ENERGY METABOLISM IN THE CENTRAL NERVOUS SYSTEM
Sokoloff, L. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb03919.x · Cited by 807
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI
Landau, S. M., Harvey, D., Madison, C. M., Koeppe, R. A., Reiman, E. M., Foster, N. L., Weiner, M. W., & Jagust, W. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.07.002 · Cited by 750
Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging
Magistretti, P. J., & Pellerin, L. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0471 · Cited by 749
Neuron-glia metabolic coupling and plasticity
Magistretti, P. J. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2010.053157 · Cited by 747
Mosconi, L., Tsui, W. H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., Reiman, E. M., Holthoff, V., Kalbe, E., Sorbi, S., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045385 · Cited by 726
Self-citationConsensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”
(1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00022-0 · Cited by 666
Sunderland, T., Linker, G., Mirza, N., Putnam, K. T., Friedman, D. L., Kimmel, L. H., Bergeson, J., Manetti, G. J., Zimmermann, M., Tang, B., et al. (2003) · JAMA · doi:10.1001/jama.289.16.2094 · Cited by 656
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Hampel, H., Frank, R., Broich, K., Teipel, S. J., Katz, R. G., Hardy, J., Herholz, K., Bokde, A. L. W., Jessen, F., Hoessler, Y. C., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3115 · Cited by 631
Self-citationFDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
Foster, N. L., Heidebrink, J. L., Clark, C. M., Jagust, W. J., Arnold, S. E., Barbas, N. R., DeCarli, C. S., Scott Turner, R., Koeppe, R. A., Higdon, R., et al. (2007) · Brain · doi:10.1093/brain/awm177 · Cited by 608
Self-citationLiang, W. S., Reiman, E. M., Valla, J., Dunckley, T., Beach, T. G., Grover, A., Niedzielko, T. L., Schneider, L. E., Mastroeni, D., Caselli, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709259105 · Cited by 585
Minoshima, S., Foster, N. L., Sima, A. A. F., Frey, K. A., Albin, R. L., & Kuhl, D. E. (2001) · Annals of Neurology · doi:10.1002/ana.1133 · Cited by 560 · cited 6×
“A significant further advancement in the use of 18F-FDG PET for suspected AD is the capacity to distinguish other neurodegeneration, such as DLB and FTD, in initial clinical evaluation (16,41).”
InfluentialSelf-citationMark, R. J., Pang, Z., Geddes, J. W., Uchida, K., & Mattson, M. P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-03-01046.1997 · Cited by 551
Mosconi, L., Mistur, R., Switalski, R., Tsui, W. H., Glodzik, L., Li, Y., Pirraglia, E., De Santi, S., Reisberg, B., Wisniewski, T., et al. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-1039-z · Cited by 487
Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies
McKeith, I. G., Ballard, C. G., Perry, R. H., Ince, P. G., O’Brien, J. T., Neill, D., Lowery, K., Jaros, E., Barber, R., Thompson, P., et al. (2000) · Neurology · doi:10.1212/wnl.54.5.1050 · Cited by 459
Metabolic Mapping of Functional Activity in the Hypothalamo-Neurohypophysial System of the Rat
Schwartz, W. J., Smith, C. B., Davidsen, L., Savaki, H., Sokoloff, L., Mata, M., Fink, D. J., & Gainer, H. (1979) · Science · doi:10.1126/science.462184 · Cited by 454
Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series
Lim, A., Tsuang, D., Kukull, W., Nochlin, D., Leverenz, J., McCormick, W., Bowen, J., Teri, L., Thompson, J., Peskind, E. R., et al. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb02571.x · Cited by 451
A NEW DEFINITION OF ALZHEIMER'S DISEASE: A HIPPOCAMPAL DEMENTIA
Ball, M. J., Hachinski, V., Fox, A., Kirshen, A. J., Fisman, M., Blume, W., Kral, V. A., Fox, H., & Merskey, H. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90965-1 · Cited by 427
Clinical-Neuropathological Correlations in Alzheimer's Disease and Related Dementias
Galasko, D., Hansen, L. A., Katzman, R., Wiederholt, W., Masliah, E., Terry, R., Hill, L. R., Lessin, P., & Thal, L. J. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540210060013 · Cited by 409
Braak, H., & Braak, E. (1996) · Acta Neuropathologica · doi:10.1007/s004010050508 · Cited by 406
FDG PET imaging in patients with pathologically verified dementia.
Hoffman, J. M., Welsh-Bohmer, K. A., Hanson, M., Crain, B. J., Hulette, C. M., Earl, N., & Coleman, R. E. (2000) · PubMed · Cited by 399
Cortical abnormalities in Alzheimer's disease
Foster, N. L., Chase, T. N., Mansi, L., Brooks, R., Fedio, P., Patronas, N. J., & Di Chiro, G. (1984) · Annals of Neurology · doi:10.1002/ana.410160605 · Cited by 372
Posterior cingulate cortex in Alzheimer's disease
MINOSHIMA, S. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92871-1 · Cited by 316 · cited 1×
“Therefore, it is the complete regional pattern of metabolic impairment of the posterior cingulate and temporoparietal cortices, more accentuated than frontal cortex deficits, together with the relative preservation of the primary sensorimotor and visual cortices, basal ganglia, and cerebellum that defines the distinct…”
Self-citationWhat does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
Jagust, W., Reed, B., Mungas, D., Ellis, W., & DeCarli, C. (2007) · Neurology · doi:10.1212/01.wnl.0000269790.05105.16 · Cited by 298
Li, Y., Rinne, J. O., Mosconi, L., Pirraglia, E., Rusinek, H., DeSanti, S., Kemppainen, N., Någren, K., Kim, B.-C., Tsui, W., et al. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0833-y · Cited by 278
Ng, S., Villemagne, V. L., Berlangieri, S., Lee, S.-T., Cherk, M., Gong, S. J., Ackermann, U., Saunder, T., Tochon-Danguy, H., Jones, G., et al. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037762 · Cited by 258
Jobst, K. A., Barnetson, L. P. D., & Shepstone, B. J. (1998) · International Psychogeriatrics · doi:10.1017/s1041610298005389 · Cited by 243
Lopponen, M., Raiha, I., Isoaho, R., Vahlberg, T., & Kivela, S.-L. (2003) · Age and Ageing · doi:10.1093/ageing/afg097 · Cited by 243
Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease
Albin, R. L., Minoshima, S., D'Amato, C. J., Frey, K. A., Kuhl, D. A., & Sima, A. A. F. (1996) · Neurology · doi:10.1212/wnl.47.2.462 · Cited by 241
Self-citationVarma, A. R., Snowden, J. S., Lloyd, J. J., Talbot, P. R., Mann, D. M. A., & Neary, D. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.184 · Cited by 238
(1998) · PubMed · Cited by 213
Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study
Diehl-Schmid, J., Grimmer, T., Drzezga, A., Bornschein, S., Riemenschneider, M., Förstl, H., Schwaiger, M., & Kurz, A. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.11.002 · Cited by 199
Comparison of 18F-FDG and PiB PET in Cognitive Impairment
Lowe, V. J., Kemp, B. J., Jack, C. R., Senjem, M., Weigand, S., Shiung, M., Smith, G., Knopman, D., Boeve, B., Mullan, B., et al. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.058529 · Cited by 192
Longitudinal Change of Biomarkers in Cognitive Decline
Lo, R. Y. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.123 · Cited by 189
Mixed Brain Pathologies in Dementia: The BrainNet Europe Consortium Experience
Kovacs, G. G., Alafuzoff, I., Al-Sarraj, S., Arzberger, T., Bogdanovic, N., Capellari, S., Ferrer, I., Gelpi, E., Kövari, V., Kretzschmar, H., et al. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000161560 · Cited by 186
Chen, K., Langbaum, J. B. S., Fleisher, A. S., Ayutyanont, N., Reschke, C., Lee, W., Liu, X., Bandy, D., Alexander, G. E., Thompson, P. M., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.064 · Cited by 169
Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease.
Herholz, K., Schopphoff, H., Schmidt, M. V., Mielke, R., Eschner, W., Scheidhauer, K., Schicha, H., Heiss, W., & Ebmeier, K. P. (2002) · PubMed · Cited by 169
Self-citationGlucose metabolism and serotonin receptors in the frontotemporal lobe degeneration
Franceschi, M., Anchisi, D., Pelati, O., Zuffi, M., Matarrese, M., Moresco, R. M., Fazio, F., & Perani, D. (2005) · Annals of Neurology · doi:10.1002/ana.20365 · Cited by 166
Alzheimer Disease: Operating Characteristics of PET— A Meta-Analysis
Patwardhan, M. B., McCrory, D. C., Matchar, D. B., Samsa, G. P., & Rutschmann, O. (2004) · Radiology · doi:10.1148/radiol.2311021620 · Cited by 162
Liu, X., Erikson, C., & Brun, A. E. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106867 · Cited by 151
Luis, C. A., Barker, W., Gajaraj, K., Harwood, D. G., Petersen, R., Kashuba, A., Waters, C., Jimison, P., Pearl, G. S., Petito, C. K., et al. (1999) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199907)14:7<526::aid-gps965>3.0.co;2-0 · Cited by 149
Piert, M., Koeppe, R. A., Giordani, B., Berent, S., & KUHL, D. E. (1996) · PubMed · Cited by 148
PATHOLOGICAL AND POSITRON EMISSION TOMOGRAPHIC CORRELATIONS IN ALZHEIMER'S DISEASE
Friedland, R. P., Brun, A. E., & Budinger, T. F. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92074-4 · Cited by 142
Impairment of Neocortical Metabolism Predicts Progression in Alzheimer’s Disease
Herholz, K., Nordberg, A. K., Salmon, É., Perani, D., Kessler, J., Mielke, R., Halber, M., Jelić, V., Almkvist, O., Collette, F., et al. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017196 · Cited by 139
Self-citationPetrie, E. C., Cross, D. J., Galasko, D. R., Schellenberg, G. D., Raskind, M. A., Peskind, E. R., & Minoshima, S. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.59 · Cited by 117
Self-citationRegional cerebral glucose metabolism and postmortem pathology in Alzheimer’s disease
Mielke, R., Schröder, R., Fink, G. R., Kessler, J., Herholz, K., & Heiß, W.-D. (1996) · Acta Neuropathologica · doi:10.1007/s004010050410 · Cited by 111
Self-citationPositron emission tomography for diagnosis of Alzheimer’s disease and vascular dementia
Mielke, R., & Heiss, W. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_21 · Cited by 105
Minoshima, S., Cross, D. J., Foster, N. L., Henry, T. R., & Kuhl, D. E. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07852.x · Cited by 91
Self-citationMassoud, F., Devi, G., Stern, Y., Lawton, A., Goldman, J. E., Liu, Y., Chin, S. S., & Mayeux, R. (1999) · Archives of Neurology · doi:10.1001/archneur.56.11.1368 · Cited by 91
Womack, K. B., Diaz-Arrastia, R., Aizenstein, H. J., Arnold, S. E., Barbas, N. R., Boeve, B. F., Clark, C. M., DeCarli, C. S., Jagust, W. J., Leverenz, J. B., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.295 · Cited by 85
Panegyres, P. K., Rogers, J. M., McCarthy, M., Campbell, A., & Wu, J. S. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-41 · Cited by 81
Mosconi, L., Tsui, W.-H., Pupi, A., Santi, S. D., Drzezga, A. E., Minoshima, S., & de Leon, M. J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.040675 · Cited by 77
Self-citationImaging local brain function with emission computed tomography.
KUHL, D. E. (1984) · Radiology · doi:10.1148/radiology.150.3.6607481 · Cited by 64
Positron Emission Tomography Scans Obtained for the Evaluation of Cognitive Dysfunction
Silverman, D. H. S., Mosconi, L., Ercoli, L. M., Chen, W., & Small, G. W. (2008) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2008.02.006 · Cited by 58
Laforce, R. J., Buteau, J. P., Paquet, N., Verret, L., Houde, M., & Bouchard, R. W. (2010) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317510363468 · Cited by 56
Similarities of cerebral glucose metabolism in Alzheimer's and Parkinsonian dementia
Kuhl, D., Metter, E. J., Benson, D. F., Ashford, J. W., Riege, W. H., Fujikawa, D. G., Markham, C. H., & Maltese, A. (1985) · Journal of Nuclear Medicine · Cited by 51
Pattern of glucose hypometabolism in frontotemporal dementia with motor neuron disease
Jeong, Y., Park, K. C., Cho, S. S., Kim, E. J., Kang, S. J., Kim, S. E., Kang, E., & Na, D. L. (2005) · Neurology · doi:10.1212/01.wnl.0000152047.58767.9d · Cited by 50
Döbert, N., Pantel, J., Frölich, L., Hamscho, N., Menzel, C., & Grünwald, F. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000085857 · Cited by 50
Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography
Burke, J. F., Albin, R. L., Koeppe, R. A., Giordani, B., Kilbourn, M. R., Gilman, S., & Frey, K. A. (2011) · Brain · doi:10.1093/brain/awr089 · Cited by 49
Longitudinal Changes of Cerebral Glucose Metabolism in Semantic Dementia
Diehl‐Schmid, J., Grimmer, T., Drzezga, A. E., Bornschein, S., Perneczky, R., Förstl, H., Schwaiger, M., & Kurz, A. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000095624 · Cited by 48
Yakushev, I. Y., Schreckenberger, M., Müller, M. J., Schermuly, I., Cumming, P. D., Stoeter, P., Gerhard, A., & Fellgiebel, A. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1882-1 · Cited by 46
Chen, W.-P., Samuraki, M., Yanase, D., Shima, K., Takeda, N., Ono, K., Yoshita, M., Nishimura, S., Yamada, M., & Matsunari, I. (2008) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3282f3fa76 · Cited by 39
Interrater reliability in the neuropathologic diagnosis of Alzheimer's disease
Paulus, W., Bancher, C., & Jellinger, K. A. (1992) · Neurology · doi:10.1212/wnl.42.2.329 · Cited by 38
Ascertainment Bias in the Clinical Diagnosis of Alzheimer Disease
Storandt, M., & Morris, J. C. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.272 · Cited by 37
Medial temporal lobe metabolic impairment in dementia associated with motor neuron disease
Garraux, G., Salmon, É., Degueldre, C., Lemaire, C. F., & Franck, G. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00188-4 · Cited by 36
Positron Emission Tomography Facilitates Diagnosis of Early-Onset Alzheimer’s Disease
McMurtray, A. M., Licht, E. A., Yeo, T., Krisztal, E., Saul, R. E., & Mendez, M. F. (2007) · European Neurology · doi:10.1159/000109258 · Cited by 35
MEDICAL AND SURGICAL INTELLIGENCE.
NA (1823) · The Lancet · doi:10.1016/s0140-6736(01)18841-0 · Cited by 29
Functional Imaging, the Frontal Lobes, and Dementia
Friedland, R. P., Koss, E., Lerner, A. J., Hedera, P., Ellis, W. G., Dronkers, N. F., Ober, B. A., & Jagust, W. J. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107323 · Cited by 26
The Value of Positron Emission Tomography in the Clinical Evaluation of Dementia
Gill, S. S., Rochon, P. A., Guttman, M., & Laupacis, A. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51067.x · Cited by 22
The Utility of PET Brain Imaging in the Initial Evaluation of Dementia
Weaver, J. D., Espinoza, R. T., & Weintraub, N. T. (2006) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2006.10.004 · Cited by 14
FDG-PET for early assessment of Alzheimer’s disease: isn’t the evidence base large enough?
Lucignani, G., & Nobili, F. M. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1535-9 · Cited by 13
Price (1999) · doi:10.1002/1531-8249(199903)45:3
(2008) · PubMed
Cited by
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321
Preclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.002 · Cited by 1,925
Plasma phospholipids identify antecedent memory impairment in older adults
Mapstone, M., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3466 · Cited by 1,043
Qiu, S., Joshi, P. S., Miller, M. I., Xue, C., Zhou, X., Karjadi, C., Chang, G. H., Joshi, A. S., Dwyer, B., Zhu, S., et al. (2020) · Brain · doi:10.1093/brain/awaa137 · Cited by 472
Multimodal deep learning for Alzheimer's disease dementia assessment
Qiu, S., Miller, M. I., Joshi, P. S., Lee, J. C., Xue, C., Ni, Y., Wang, Y., De Anda-Duran, I., Hwang, P. H., Cramer, J. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31037-5 · Cited by 420
Metadata
- Authors
- Bohnen, N. I., Djang, D. S. W., Herholz, K., Anzai, Y., & Minoshima, S.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2011-12-15
- Volume
- 53
- Issue
- 1
- Pages
- 59-71
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2132680220
- Cited by
- 286
- References
- 96
- FWCI
- 15.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.